Computational analysis of EBNA1 “druggability” suggests novel insights for Epstein-Barr virus inhibitor design
Crossref DOI link: https://doi.org/10.1007/s10822-016-9899-y
Published Online: 2016-04-05
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gianti, Eleonora
Messick, Troy E.
Lieberman, Paul M.
Zauhar, Randy J.
Funding for this research was provided by:
Wellcome Trust (GB) ((096496/Z/11/Z))
American Cancer Society (US) (ACS- IRG-96-153-10)
Text and Data Mining valid from 2016-04-01